obtain a more complete picture on both the molecular mechanism(s) of action of
membrane-active peptides and the role of the lipids in determining the mode of
interaction. Although biophysical studies using model systems have already revealed
quite some insight into the molecular mechanisms of action of membrane-active
peptides, the specificity towards particular lipid components is not yet totally un-
derstood, and the occurrence of binding preferences to certain lipid types cannot be
quantitatively related to the peptide specificity toward given cell membranes [29].
Therefore, care has to be taken, when these results are related to the biological
activity of these peptides.
1.2. Effects of Antimicrobial Peptides on Lipid Bilayers
Given the rapid emergence of antibiotic-resistant bacterial strains, the development
of alternatives to conventional antibiotics has become an imperative [30]. Anti-
microbial peptides (or host-defense peptides), effector molecules of the innate im-
mune system, which confer a first-line defense against bacteria, viruses, fungi and
even cancer cells promise to be a solution to this problem [30–35]. The main
advantage of this class of substances, when considering bacterial resistance, is their
mode of action. Whereas conventional antibiotics act rather slowly up to hours via
interference with protein synthesis, cell-wall formation or DNA replication of
bacteria, antimicrobial peptides unfold their effect within minutes, faster than the
growth-rate of bacteria, which makes the development of resistance less likely. The
mechanisms, by which antimicrobial peptides can kill bacterial cells are diverse and
range from direct disruption of the cell membrane via pore formation, micellization
or other modes of membrane damage to binding to specific lipids or cytoplasmic
targets [36,37]. However, independent from the killing mechanism, the peptides
have to interact with the cell membrane by either disrupting or transversing this
barrier. Antimicrobial peptides distinguish between foreign, e.g., bacterial and host
cells based on differences in the composition of the cell membrane. Therefore, it is
essential to consider membrane architecture and lipid compositions in order to
understand the molecular mechanism and target-cell specificity of these peptides.
As outlined before, the outer layer of eukaryotic cell membranes predominantly
contains zwitterionic PC, SM and cholesterol, whereas bacterial cell membranes are
composed of negatively charged PG and neutral PE. Due to their cationic nature,
most antimicrobial peptides preferentially interact with negatively charged mem-
branes; however, lipid molecular shape and global membrane properties play a role,
as well. Thus, understanding the parameters of peptide–membrane interaction is
crucial for the elucidation of the molecular mechanisms of action. This knowledge,
in turn, will allow the design of novel peptide antibiotics killing their target cells by
destruction of their phospholipid membrane integrity.
Naturally, the mode of interaction of antimicrobial peptides (AMPs) with
membranes is, on the one hand, dependent on the nature of the peptide and, on the
other hand, on the membrane lipid composition, a factor that, in the past, has often
been overlooked [36]. Two classical models regarding membrane permeation and
disruption have originally been proposed: the ‘‘carpet’’ mechanism and formation
of transmembrane pores [38,39]. Numerous studies have been aimed at elucidating
Liposome-Based Biomembrane Mimetic Systems 109